blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0735893

EP0735893 - PAN DR-BINDING PEPTIDES FOR ENHANCEMENT OF THE IMMUNE RESPONSE [Right-click to bookmark this link]
Former [1996/41]ALTERATION OF IMMUNE RESPONSE USING PAN DR-BINDING PEPTIDES
[2006/40]
StatusNo opposition filed within time limit
Status updated on  02.10.2009
Database last updated on 28.06.2024
Most recent event   Tooltip02.10.2009No opposition filed within time limitpublished on 04.11.2009  [2009/45]
Applicant(s)For all designated states
Pharmexa Inc.
5820 Nancy Ridge Drive, Suite 100
San Diego, CA 92121 / US
[2006/43]
Former [1999/24]For all designated states
Epimmune Inc.
6555 Nancy Ridge Drive, Suite 200
San Diego, California 92121 / US
Former [1998/32]For all designated states
Epimmune, Inc.
6555 Nancy Ridge Drive, Suite 200
San Diego, California 92121 / US
Former [1996/41]For all designated states
CYTEL CORPORATION
3525 John Hopkins Court
San Diego, CA 92121 / US
Inventor(s)01 / SETTE, Alessandro
5531 Beaumont Avenue
La Jolla, CA 92037 / US
02 / GAETA, Federico C.A.
3226 Rim Rock Circle
Olivenhain, CA 92024 / US
03 / GREY, Howard M.
8307 Caminito Helecho
La Jolla, CA 92037 / US
04 / SIDNEY, John
8541-D Villa La Jolla Drive
La Jolla, CA 92037 / US
05 / ALEXANDER, Jerrery L.
117 Mangano Circle
Encinitas, CA 92024 / US
[1996/41]
Representative(s)Armitage, Ian Michael, et al
Mewburn Ellis LLP
York House
23 Kingsway
London WC2B 6HP / GB
[N/P]
Former [1996/41]Armitage, Ian Michael, et al
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date94929801.214.09.1994
[1996/41]
WO1994US10368
Priority number, dateUS1993012110114.09.1993         Original published format: US 121101
[1996/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9507707
Date:23.03.1995
Language:EN
[1995/13]
Type: A1 Application with search report 
No.:EP0735893
Date:09.10.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 23.03.1995 takes the place of the publication of the European patent application.
[1996/41]
Type: B1 Patent specification 
No.:EP0735893
Date:26.11.2008
Language:EN
[2008/48]
Search report(s)International search report - published on:US23.03.1995
(Supplementary) European search report - dispatched on:EP18.12.1997
ClassificationIPC:A61K39/39, A61K38/00, C07K1/00, C07K5/00, C07K7/00, C07K14/00, C07K17/00
[2006/40]
CPC:
C07K7/08 (EP,US); A61P37/00 (EP); A61P37/04 (EP);
A61P37/06 (EP); A61P37/08 (EP); C07K14/001 (EP,US);
C07K14/005 (EP,US); C07K14/70539 (EP,US); A61K38/00 (EP,US);
C12N2730/10122 (EP,US); Y10S530/868 (EP) (-)
Former IPC [1996/41]A61K38/00, C07K1/00, C07K5/00, C07K7/00, C07K14/00, C07K17/00
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1996/41]
TitleGerman:PAN DR-BINDEPROTEINEN ZUR ERHÖHUNG DER IMMUNANTWORT[2006/40]
English:PAN DR-BINDING PEPTIDES FOR ENHANCEMENT OF THE IMMUNE RESPONSE[2006/40]
French:PEPTIDES SE LIANT A DES ALLELES PAN DR POUR L'AUGMENTATION DE LA REPONSE IMMUNITAIRE[2006/40]
Former [1996/41]VERÄNDERUNG DER IMMUNANTWORT DURCH VERWENDUNG VON PAN DR-BINDEPROTEINEN
Former [1996/41]ALTERATION OF IMMUNE RESPONSE USING PAN DR-BINDING PEPTIDES
Former [1996/41]ALTERATION DE LA REPONSE IMMUNITAIRE A L'AIDE DE PEPTIDES SE LIANT A DES ALLELES PAN DR
Entry into regional phase04.04.1996National basic fee paid 
04.04.1996Search fee paid 
04.04.1996Designation fee(s) paid 
04.04.1996Examination fee paid 
Examination procedure22.03.1995Request for preliminary examination filed
International Preliminary Examining Authority: US
04.04.1996Examination requested  [1996/41]
03.11.1999Despatch of a communication from the examining division (Time limit: M06)
12.05.2000Reply to a communication from the examining division
25.03.2002Despatch of a communication from the examining division (Time limit: M06)
09.09.2002Reply to a communication from the examining division
07.01.2004Despatch of a communication from the examining division (Time limit: M06)
19.07.2004Reply to a communication from the examining division
19.09.2006Date of oral proceedings
29.09.2006Despatch of a communication from the examining division (Time limit: M02)
29.09.2006Minutes of oral proceedings despatched
04.12.2006Reply to a communication from the examining division
30.03.2007Despatch of a communication from the examining division (Time limit: M04)
19.07.2007Reply to a communication from the examining division
21.08.2007Communication of intention to grant the patent
11.02.2008Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
16.04.2008Fee for grant paid
16.04.2008Fee for publishing/printing paid
Divisional application(s)EP08169874.8   Application deemed to be withdrawn  : 26.02.2009
Opposition(s)27.08.2009No opposition filed within time limit [2009/45]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
16.04.2008Request for further processing filed
16.04.2008Full payment received (date of receipt of payment)
Request granted
10.06.2008Decision despatched
Fees paidRenewal fee
19.08.1996Renewal fee patent year 03
22.08.1997Renewal fee patent year 04
18.11.1998Renewal fee patent year 05
23.08.1999Renewal fee patent year 06
28.08.2000Renewal fee patent year 07
24.09.2001Renewal fee patent year 08
23.09.2002Renewal fee patent year 09
24.09.2003Renewal fee patent year 10
23.09.2004Renewal fee patent year 11
21.09.2005Renewal fee patent year 12
27.09.2006Renewal fee patent year 13
26.09.2007Renewal fee patent year 14
25.09.2008Renewal fee patent year 15
Penalty fee
Additional fee for renewal fee
30.09.199805   M06   Fee paid on   18.11.1998
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9202543  (CYTEL CORP [US], et al) [X] 1-4,11-17 * page 8, paragraph L * * page 10, paragraph L - page 12 * * page 5 - page 6 * * page 15, paragraph 2 * * page 26; claims 1,2,7,8,13 *;
 [XY]WO9305011  (SANDOZ LTD [CH], et al) [X] 1-4,11-17 * page 57, paragraph L; claims 1-3; table 1 * [Y] 5-10;
 [Y]EP0534615  (CYTEL CORP [US]) [Y] 5-10 * claims 7,11,13,20 * * page 3, line 23 - line 29 * * page 9, line 39 - page 10, line 7 *;
 [X]  - M.F. POWELL, "Peptide stability in drug development", PHARM. RES., (199309), vol. 10, no. 9, pages 1268 - 1273, XP000569558 [X] 1-4,11-17 * page 1272, column 1; figures 1,5 *

DOI:   http://dx.doi.org/10.1023/A:1018953309913
 [A]  - D. O'SULLIVAN ET AL, "On the interaction of promiscuous antigenic peptides with different DR alleles", J. IMMUNOLOGY, (199110), vol. 147, no. 8, pages 2663 - 2669, XP002046346 [A] * page 2669, column 1 *
 [A]  - J.H. BROWN ET AL, "Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1", NATURE, (199307), vol. 364, pages 33 - 39, XP002046347 [A] * the whole document *

DOI:   http://dx.doi.org/10.1038/364033a0
 [T]  - J. ALEXANDER ET AL, "Development of High potency universal DR-Restricted Helper Epitopes by modification of high affinity DR-blocking peptides", IMMUNITY, (199412), vol. 1, pages 751 - 761, XP000673954

DOI:   http://dx.doi.org/10.1016/S1074-7613(94)80017-0
International search[Y]US5114713  (SINIGAGLIA FRANCESCO [CH]);
 [Y]US5196512  (BIANCHI ELISABETTA [US], et al);
 [YP]US5336758  (BERZOFSKY JAY A [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.